Follow The Filings

ALLT Allot

Allot earnings company data as of 4:47 AM ET 10/25

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 19 Nov EPS 0.05 — —
Rev — — —

Insider trades

Open-market buys and sales by ALLT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALLT insider trades
  • None no insider bought on the open market
  • $677K sold by 5 insiders outside a trading plan
  • $210K sold by 1 insider under 10b5-1 plans
  1. Boaz Grossman Senior Vice President R&D
    Sale
    $31K 4,000 shares at $7.80 2.2% of stake
    Traded Aug 28 Filed Aug 31
  2. Boaz Grossman Senior Vice President R&D
    Sale
    $45K 6,000 shares at $7.45 3.1% of stake
    Traded Aug 21 Filed Aug 24
  3. Gili Groner Chief Human Resources Officer
    Planned sale
    $210K 26,666 shares at $7.86 31% of stake
    Traded Aug 18 Filed Aug 19
  4. Eyal David Harari CEO
    Sale
    $222K 29,111 shares at $7.64 2.6% of stake
    Traded Aug 6 Filed Aug 10
  5. Inbar Charash General Counsel
    Sale
    $4,335 556 shares at $7.80 1.9% of stake
    Traded Aug 3 Filed Aug 4
  6. Mark Shteiman Chief Product Officer
    Sale
    $15K 2,000 shares at $7.50 0.9% of stake
    Traded Jun 15 Filed Jun 16
  7. Noam Lelah SVP Customer Success & Ops
    Sale
    $178K 21,000 shares at $8.48 11% of stake
    Traded Jun 1 Filed Jun 2
  8. Mark Shteiman Chief Product Officer
    Sale
    $82K 11,000 shares at $7.49 4.9% of stake
    Traded May 21–22 Filed May 26
  9. Boaz Grossman Senior Vice President R&D
    Sale
    $37K 5,000 shares at $7.37 2.5% of stake
    Traded May 20 Filed May 21
  10. Mark Shteiman Chief Product Officer
    Sale
    $37K 5,000 shares at $7.32 2.2% of stake
    Traded May 19 Filed May 20
  11. Mark Shteiman Chief Product Officer
    Sale
    $21K 3,000 shares at $7.13 1.3% of stake
    Traded May 18 Filed May 19
  12. Inbar Charash General Counsel
    Sale
    $4,114 556 shares at $7.40 1.9% of stake
    Traded May 1 Filed May 4

Also filed in the last 12 months, not counted as buying or selling: 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K
6-K
6-K
6-K
SCHEDULE 13D/A —
6-K
SCHEDULE 13D —
6-K
SCHEDULE 13G —
6-K
6-K
20-F/A
20-F
6-K
6-K
SCHEDULE 13D/A —
6-K
SCHEDULE 13D/A —
6-K
6-K
6-K
6-K
6-K
SCHEDULE 13D/A —
6-K REPORT OF FOREIGN PRIVATE ISSUER

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.